Alveolar macrophages comprising up to 95% of the pulmonary alveoli, are the gate-keepers of homeostasis by ensuring efficient tissue function through metabolizing excessive surfactant and phagocyting inhaled day-to-day and innocuous pathogens and particles, without triggering an immune response. Despite that, they are capable of orchestrating a very well-balanced immune response upon invasion of pathogens. These embryonic-derived cells are capable of self-renewal and therefore maintain themselves in the lungs throughout adult life, with minimal contribution from the circulating monocytes. This self-renewal capacity is attained intrinsically by maintaining low levels of transcription factors MafB and cMaf, and extrinsically through two main cytokines, namely GM-CSF secreted by alveolar epithelial type II cells, and TGFb secreted by AMs themselves in an autocrine manner. However, in inflammatory conditions such as acute respiratory distress syndrome (ARDS), depletion of AM pool and upregulation of MAFB among lung macrophages have been reported. Keeping in mind the role of transcription factors MafB and cMaf in inhibiting proliferative capacity of macrophages; we hypothesized that this depletion is due to upregulation of MafB and hence the suppression of enhancer regions of self-renewal genes in AMs. To investigate the role of MafB and its compensatory partner cMaf in ARDS, we have established a mouse model of ARDS using oropharyngeal instillation of LPS in WT and MafB/cMaf double-knockout (Maf-DKO) mice. Alongside, the molecular mechanisms of the effect of LPS on AMs was investigated ex-vivo. The obtained results have clearly shown that ex-vivo, LPS inhibits proliferation of AMs in a dose dependent manner, and induces apoptosis significantly. Regain of proliferative potential of LPS-stimulated AMs was evident upon TLR4 inhibition, and MyD-88 was shown to be the dominant adaptor downstream of TLR4 (as opposed to TRIF). Both WT and DKO AMs responded to LPS stimulation within 2 hours, by switching from OXPHOS to glycolysis, which accounts for their efficient pro-inflammatory phenotype once activated. Upon activation, MafB and cMaf were upregulated after 48 hours and the inhibition of AM proliferation was shown to be Maf-independent. Similarly, depletion of AM pool was shown to be Maf independent invivo, evident by similar kinetics of AM numbers in WT and DKO at different timepoints upon LPS stimulation. However, several findings indicated potential advantage of Maf-deficiency in tissue regeneration; this includes: 1) higher number of Ly6C+ monocytes and their earlier differentiation into resident AMs, 2) lower degree of tissue damage revealed by H&E staining, 3) higher number of alveolar epithelial type II cells, 4) significantly higher levels of cytotoxicity pointing towards cellular turnover, and 5) significantly higher levels of SP-D and thus its antiinflammatory effects. In a quest for investigating factors which could enhance proliferative potential of AMs and ultimately neutralize the inhibitory effect of LPS, the impact of TGFb and ActivinA was studied. I have shown that TGFb and to a higher extend ActivinA boost the proliferation rate of AMs, ex-vivo. The autocrine effect of these cytokines was validated by blocking signal transduction through inhibition of SMAD2/3, which resulted in a significant increase in doubling time of AMs. Interestingly, Inhba was shown to be significantly upregulated in AMs, as opposed to TGFb. The importance of ActivinA was further demonstrated by its direct inhibition and the resulting reduction in growth rate of AMs. On the contrary to the significant role of these cytokines in enhancing the growth rate of AMs ex-vivo, they could rescue AM proliferation under the effect of LPS. In conclusion, I have demonstrated that LPS inhibits AM proliferation in a dose dependent and Maf-independent manner. Furthermore, neither TGFb nor ActivinA could rescue proliferation of LPS-stimulated AMs. Although Maf-deficiency was not shown to be beneficial during the inflammatory phase of ARDS, due to the fact that both WT and DKO AMs were equally depleted at the peak of inflammation, multiple data indicated potential advantage of Maf deficiency during resolution phase.
| Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:90342 |
| Date | 03 June 2024 |
| Creators | Gholamhosseinian Najjar, Sara |
| Contributors | Bornhäuser, Martin, Wielockx, Ben, Technische Universität Dresden |
| Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
| Language | English |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, doc-type:doctoralThesis, info:eu-repo/semantics/doctoralThesis, doc-type:Text |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.002 seconds